International travel‐related control measures to contain the COVID‐19 pandemic (search up to 13 November 2020)
Citation: Burns J, Movsisyan A, Stratil JM, et al. International travel‐related control measures to contain the COVID‐19 pandemic: a rapid review. Cochrane Database of Systematic Reviews. 2021;(3):CD013717.
Podcast available here.
What is this? The COVID-19 pandemic has led several countries to implement travel-related control measures to minimize transmission of the SARS-Cov-2 virus.
In this version of the Cochrane rapid review, the authors searched for studies on control measures for international travel during the COVID-19 pandemic. They did not restrict their searches by language of publication and did the search up to 13 November 2020. The review updates an earlier version of the review, which also included data from other pandemics. This version includes 49 modelling studies and 13 observational studies.
What was found: At the time of this version of the review, the included evidence (based on 31 modelling studies) suggest that travel restrictions reducing or stopping cross‐border travel were beneficial at reducing the transmission of SARS-CoV-2.
At the time of this version of the review, the included evidence (based on 13 modelling studies and 13 observational studies) suggest that screening travellers at borders (including those with symptoms or who had potentially been exposed to COVID‐19) would reduce imported or exported cases of COVID-19 and delay outbreaks. While, for screening based on testing, the studies reported that testing travellers reduced imported or exported cases, and cases detected.
At the time of this version of the review, the included evidence (based on 12 modelling studies) suggest that quarantine may be beneficial for preventing the transmission of SARS-CoV-2.
At the time of this version of the review, the included evidence (based on 7 modelling studies and 4 observational studies) suggest that quarantine and screening at borders may be beneficial for preventing the transmission of SARS-CoV-2.
Disclaimer: This summary has been written by staff and volunteers of Evidence Aid in order to make the content of the original document accessible to decision makers who are searching for the available evidence on the coronavirus (COVID-19) but may not have the time, initially, to read the original report in full. This summary is not intended as a substitute for the medical advice of physicians, other health workers, professional associations, guideline developers, or national governments and international agencies. If readers of this summary think that the evidence that is presented within it is relevant to their decision-making they should refer to the content and details of the original article, and the advice and guidelines offered by other sources of expertise, before making decisions. Evidence Aid cannot be held responsible for any decisions made about the coronavirus (COVID-19) on the basis of this summary alone. The text can be shared and re-used without charge, citing Evidence Aid as the source and noting the date on which you took the text.
If you have found this summary helpful, please consider making a donation. If everyone who looked at our COVID-19 resources gave us just £2 per month, it would fund Evidence Aid’s life-saving work.